Latest Market News

Felix Gold Limited confirms strong continuity and high-grade antimony mineralisation at its NW Array project in Alaska, positioning for near-term production to address critical US supply shortages amid China's export ban.

Renegade Exploration Limited has secured an option over the Fireball Ridge Gold-Silver Project in Nevada, marking its fifth project in the prolific Walker Lane Trend and setting the stage for renewed exploration activity.

Auris Minerals has raised $3.2 million through a strategic placement to expand its geological team and fast-track exploration in the Bryah Basin, focusing on copper, gold, and rare earths.

G50 Corp’s latest quarterly report reveals a significant new precious metals discovery at its Golconda Project alongside promising antimony results at White Caps, supported by a $10 million capital raise to advance exploration.

Qualitas Real Estate Income Fund (QRI) has announced a $162 million non-renounceable entitlement offer at $1.60 per unit, aiming to capitalize on a robust pipeline of commercial real estate loans. The offer provides existing investors an opportunity to deepen exposure to Australia's evolving private credit market.

Carnaby Resources has completed the acquisition of the remaining 17.5% stake in the Greater Duchess Copper Gold Joint Venture, gaining 100% ownership and full operational control. This strategic move positions Carnaby to accelerate development and unlock the project’s significant copper-gold potential.

Latitude 66 has completed the sale of its 17.5% stake in the Greater Duchess Joint Venture to Carnaby Resources for A$6 million, eliminating debt and boosting funds for exploration.

EV Resources has appointed Michael Brown as Managing Director and CEO to spearhead its North American antimony supply strategy, aiming to restart production in Mexico and expand U.S. projects amid rising demand for critical minerals.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

TrivarX Limited has resumed trading on the ASX following the announcement of a significant acquisition and a fresh capital raising, signaling a pivotal moment for the biotech company.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Pilot Energy teams up with Kala Data to launch a modular data centre powered by surplus gas-fired energy, aiming for early cash flow and ambitious expansion plans.